BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30320920)

  • 1. MORC4 is a novel breast cancer oncogene regulated by miR-193b-3p.
    Yang Z; Zhuang Q; Hu G; Geng S
    J Cell Biochem; 2019 Mar; 120(3):4634-4643. PubMed ID: 30320920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of metastamiR-193b and breast cancer metastasis suppressor 1 as an anti-metastatic strategy.
    Hashemi ZS; Forouzandeh Moghadam M; Khalili S; Ghavami M; Salimi F; Sadroddiny E
    Breast Cancer; 2019 Mar; 26(2):215-228. PubMed ID: 30284194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalin Inhibits Cell Viability, Migration and Invasion in Breast Cancer by Regulating miR-338-3p and MORC4.
    Duan X; Guo G; Pei X; Wang X; Li L; Xiong Y; Qiu X
    Onco Targets Ther; 2019; 12():11183-11193. PubMed ID: 31908485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-strand tumor suppressor miR-193b-3p and -5p inhibit malignant phenotypes of lung cancer by suppressing their common targets.
    Choi KH; Shin CH; Lee WJ; Ji H; Kim HH
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.
    Shin CH; Lee H; Kim HR; Choi KH; Joung JG; Kim HH
    Cell Death Differ; 2017 Nov; 24(11):1861-1871. PubMed ID: 28708135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1.
    Long J; Ji Z; Jiang K; Wang Z; Meng G
    Biomed Res Int; 2015; 2015():373574. PubMed ID: 26526790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of lncRNA-ATB inhibits epithelial-mesenchymal transition of breast cancer cells by increasing miR-141-3p expression.
    Zhang Y; Li J; Jia S; Wang Y; Kang Y; Zhang W
    Biochem Cell Biol; 2019 Apr; 97(2):193-200. PubMed ID: 30352165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-548-3p functions as an anti-oncogenic regulator in breast cancer.
    Shi Y; Qiu M; Wu Y; Hai L
    Biomed Pharmacother; 2015 Oct; 75():111-6. PubMed ID: 26297544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.
    Yang Z; He M; Wang K; Sun G; Tang L; Xu Z
    Int J Clin Exp Pathol; 2014; 7(11):7563-70. PubMed ID: 25550792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact.
    Leivonen SK; Rokka A; Ostling P; Kohonen P; Corthals GL; Kallioniemi O; Perälä M
    Mol Cell Proteomics; 2011 Jul; 10(7):M110.005322. PubMed ID: 21512034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
    J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
    Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J
    Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
    Xu X; Lv YG; Yan CY; Yi J; Ling R
    Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.
    Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J
    Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2.
    Jia Z; Liu Y; Gao Q; Han Y; Zhang G; Xu S; Cheng K; Zou W
    Gene; 2016 Nov; 593(1):41-47. PubMed ID: 27506313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased miR-124-3p Expression Prompted Breast Cancer Cell Progression Mainly by Targeting Beclin-1.
    Zhang F; Wang B; Long H; Yu J; Li F; Hou H; Yang Q
    Clin Lab; 2016; 62(6):1139-45. PubMed ID: 27468577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-129-2 by promoter hypermethylation regulates breast cancer cell proliferation and apoptosis.
    Tang X; Tang J; Liu X; Zeng L; Cheng C; Luo Y; Li L; Qin SL; Sang Y; Deng LM; Lv XB
    Oncol Rep; 2016 May; 35(5):2963-9. PubMed ID: 26935022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.